4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid is a compound that falls under the category of pharmaceutical drugs. This specific compound has relevance to everyday life as it is being studied and potentially developed for use in the treatment of certain medical conditions. Research and development of new pharmaceutical compounds like this one can lead to the creation of new medications that may improve the quality of life for individuals suffering from various ailments. Additionally, advancements in pharmaceuticals can have broader implications for public health and healthcare systems.
Table of Contents:
- 💡 Commercial Applications
- ⚗️ Chemical & Physical Properties
- 🏭 Production & Procurement
- ⚠️ Safety Considerations
- 🔬 Potential Research Directions
- 🧪 Related Compounds
💡 Commercial Applications
In terms of commercial and industrial applications, 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid, also known as CP47,497, is a synthetic cannabinoid that has been used as a research chemical in the development of novel medications targeting the endocannabinoid system. Due to its high affinity for cannabinoid receptors, CP47,497 has been studied for its potential pharmacological properties, making it a valuable tool in drug discovery.
One of the drug and medication applications of CP47,497 lies in its ability to activate the endocannabinoid system, mimicking the effects of naturally occurring cannabinoids. This has led to the compound being investigated for its potential therapeutic benefits in conditions such as pain management, neurological disorders, and psychiatric illnesses. Although not approved for human use, CP47,497 has shown promise in preclinical studies as a potential candidate for the development of novel cannabinoid-based medications.
In summary, 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid has demonstrated utility in both commercial and industrial settings as a research tool for investigating the endocannabinoid system and developing new pharmacological treatments. Its potent activity at cannabinoid receptors has positioned CP47,497 as a compound of interest in the exploration of therapeutic applications for various medical conditions. Further research is needed to fully elucidate its potential benefits and risks in the realm of drug development.
⚗️ Chemical & Physical Properties
The chemical 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid appears as a white crystalline powder with a faint odor.
With a molar mass of approximately 402.91 g/mol and a density of around 1.21 g/cm^3, 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid is heavier than common food items like sugar (molar mass around 180 g/mol) and water (density of 1 g/cm^3).
The melting point of 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid is approximately 95 degrees Celsius, while the boiling point is approximately 365 degrees Celsius. These values are significantly higher than those of common food items like butter (melting point around 32 degrees Celsius) and water (boiling point of 100 degrees Celsius).
4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid is sparingly soluble in water and has a low viscosity. This is in contrast to common food items like salt (high solubility in water) and honey (high viscosity).
🏭 Production & Procurement
In the production of 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid, a series of chemical reactions involving chlorophenyl, pyridin-2-yl, and piperidin-1-yl compounds are typically carried out in a controlled laboratory setting. These reactions may include processes such as condensation, hydrolysis, and esterification, ultimately leading to the formation of the desired compound.
4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid can be procured from specialized chemical suppliers who produce and distribute a range of pharmaceutical and research-grade compounds. It is important to ensure that the compound is obtained from a reputable source to guarantee its purity and quality. Once procured, the compound can be transported in accordance with industry regulations for the safe handling and transportation of chemical substances.
Transportation of 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid may involve packaging the compound in appropriate containers that meet regulatory requirements for hazardous materials. Shipping methods such as ground transportation or air freight may be utilized depending on the volume and destination of the shipment. It is essential to follow established safety protocols to prevent any potential hazards during the transportation of this compound.
⚠️ Safety Considerations
Safety considerations for 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid include the potential for irritation to the skin, eyes, and respiratory tract upon contact or inhalation. This compound may also be harmful if swallowed, causing gastrointestinal discomfort or other adverse effects. It is important to handle this substance with caution, using appropriate personal protective equipment such as gloves and safety goggles.
Hazard statements for 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid include “Causes skin irritation” and “May cause respiratory irritation.” These statements indicate the potential risks associated with exposure to this compound, highlighting the need for proper precautions to avoid adverse effects on human health.
Precautionary statements for 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid include “Wear protective gloves/protective clothing/eye protection/face protection” and “IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.” These statements outline specific actions that individuals should take to minimize the risks of exposure and address potential health concerns if accidental contact or ingestion occurs.
🔬 Potential Research Directions
One potential research direction for 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid could be exploring its pharmacological properties, such as its mechanism of action and potential therapeutic applications. Researchers may investigate its interactions with specific receptors or enzymes to elucidate its effects on biological systems.
Another area of interest could be conducting pharmacokinetic studies to determine the compound’s absorption, distribution, metabolism, and excretion in vivo. This could provide valuable insights into its bioavailability and potential for clinical use. Additionally, investigating the compound’s stability and formulation could be crucial for drug development efforts.
Furthermore, investigating the structure-activity relationship of 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid could lead to the development of more potent analogs with improved pharmacological profiles. Researchers may explore modifications to the molecular structure to enhance its efficacy, reduce toxicity, or improve other pharmacokinetic properties. This could involve synthesizing and testing a series of analogs to identify the most promising candidates for further development.
Additionally, exploring the potential use of 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid in combination therapy or in different disease models could provide valuable insights into its therapeutic potential. Investigating its effects in various cell lines or animal models of disease could help determine its efficacy and specificity in different biological contexts. Such studies could pave the way for the development of novel treatment strategies leveraging the compound’s unique pharmacological properties.
🧪 Related Compounds
One similar compound to 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid is 4-(4-(Phenyl(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid. This compound shares a similar structure to the original compound, but with a phenyl group instead of a chlorophenyl group. The presence of the pyridin-2-yl group remains the same in both compounds.
Another similar compound is 4-(4-((4-Methylphenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid. In this compound, the chlorophenyl group is replaced with a methylphenyl group, providing a variation in the structure. The pyridin-2-yl group is still present in this compound, maintaining some similarity to the original compound.
A third similar compound is 4-(4-((4-Fluorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid. This compound features a fluorophenyl group in place of the chlorophenyl group in the original compound. The pyridin-2-yl group is maintained in this compound, contributing to its similarity to the parent compound. These compounds showcase variations in structure while sharing common elements, highlighting the versatility of compounds with similar molecular frameworks.
